End-of-day quote
Korea S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
2,770
KRW
|
+0.73%
|
|
+3.55%
|
-3.15%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
163,207
|
139,614
|
272,301
|
179,875
|
126,410
|
123,813
|
Enterprise Value (EV)
1 |
147,816
|
119,914
|
238,625
|
128,832
|
70,449
|
48,884
|
P/E ratio
|
16.9
x
|
14.7
x
|
25.9
x
|
14.6
x
|
12.1
x
|
8.29
x
|
Yield
|
1.33%
|
1.55%
|
0.79%
|
1.2%
|
2.05%
|
-
|
Capitalization / Revenue
|
2.54
x
|
2.09
x
|
4.27
x
|
2.87
x
|
2.1
x
|
1.81
x
|
EV / Revenue
|
2.3
x
|
1.79
x
|
3.74
x
|
2.06
x
|
1.17
x
|
0.72
x
|
EV / EBITDA
|
8.75
x
|
5.88
x
|
13.6
x
|
6.7
x
|
4.38
x
|
2.38
x
|
EV / FCF
|
28.5
x
|
14.6
x
|
17.8
x
|
7.97
x
|
17.1
x
|
2.99
x
|
FCF Yield
|
3.5%
|
6.83%
|
5.62%
|
12.5%
|
5.84%
|
33.4%
|
Price to Book
|
1.89
x
|
1.47
x
|
2.67
x
|
1.58
x
|
1.03
x
|
0.92
x
|
Nbr of stocks (in thousands)
|
43,291
|
43,291
|
43,291
|
43,291
|
43,291
|
43,291
|
Reference price
2 |
3,770
|
3,225
|
6,290
|
4,155
|
2,920
|
2,860
|
Announcement Date
|
3/21/19
|
3/16/20
|
3/19/21
|
3/23/22
|
3/21/23
|
3/20/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
64,286
|
66,869
|
63,729
|
62,579
|
60,116
|
68,247
|
EBITDA
1 |
16,886
|
20,405
|
17,581
|
19,222
|
16,075
|
20,568
|
EBIT
1 |
13,768
|
16,908
|
13,897
|
15,386
|
12,187
|
16,920
|
Operating Margin
|
21.42%
|
25.29%
|
21.81%
|
24.59%
|
20.27%
|
24.79%
|
Earnings before Tax (EBT)
1 |
14,291
|
17,231
|
13,337
|
16,626
|
13,629
|
19,298
|
Net income
1 |
9,672
|
9,476
|
10,496
|
12,282
|
10,406
|
14,957
|
Net margin
|
15.05%
|
14.17%
|
16.47%
|
19.63%
|
17.31%
|
21.92%
|
EPS
2 |
223.4
|
218.9
|
242.4
|
283.7
|
240.4
|
345.0
|
Free Cash Flow
1 |
5,178
|
8,195
|
13,411
|
16,161
|
4,115
|
16,336
|
FCF margin
|
8.05%
|
12.26%
|
21.04%
|
25.82%
|
6.84%
|
23.94%
|
FCF Conversion (EBITDA)
|
30.66%
|
40.16%
|
76.28%
|
84.07%
|
25.6%
|
79.42%
|
FCF Conversion (Net income)
|
53.53%
|
86.49%
|
127.78%
|
131.59%
|
39.54%
|
109.22%
|
Dividend per Share
2 |
50.00
|
50.00
|
50.00
|
50.00
|
60.00
|
-
|
Announcement Date
|
3/21/19
|
3/16/20
|
3/19/21
|
3/23/22
|
3/21/23
|
3/20/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
15,391
|
19,699
|
33,676
|
51,042
|
55,961
|
74,929
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
5,178
|
8,195
|
13,411
|
16,161
|
4,115
|
16,336
|
ROE (net income / shareholders' equity)
|
12.1%
|
15.7%
|
10.6%
|
11.6%
|
8.83%
|
11.8%
|
ROA (Net income/ Total Assets)
|
9.41%
|
10.5%
|
8.12%
|
8.21%
|
5.92%
|
7.58%
|
Assets
1 |
102,816
|
90,274
|
129,297
|
149,588
|
175,701
|
197,368
|
Book Value Per Share
2 |
1,995
|
2,199
|
2,356
|
2,636
|
2,841
|
3,104
|
Cash Flow per Share
2 |
407.0
|
470.0
|
800.0
|
1,036
|
739.0
|
1,739
|
Capex
1 |
5,414
|
5,934
|
2,274
|
2,224
|
2,151
|
1,949
|
Capex / Sales
|
8.42%
|
8.87%
|
3.57%
|
3.55%
|
3.58%
|
2.86%
|
Announcement Date
|
3/21/19
|
3/16/20
|
3/19/21
|
3/23/22
|
3/21/23
|
3/20/24
|
|
1st Jan change
|
Capi.
|
---|
| -3.15% | 87.12M | | +11.84% | 27.79B | | -32.98% | 2.98B | | -15.97% | 2.52B | | +11.90% | 2.34B | | -1.11% | 1.91B | | -7.78% | 1.39B | | -0.38% | 1.27B | | +4.01% | 1.13B | | +13.51% | 1.12B |
Medical Supplies
|